These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 6474407
1. In vitro effect of cimetidine on ADP induced platelet aggregation and thromboxane A2 synthesis in man. Gachályi B, Tihanyi K, Vas A, Káldor A. Thromb Res; 1984 Jul 01; 35(1):105-9. PubMed ID: 6474407 [No Abstract] [Full Text] [Related]
2. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation. Rettkowski W, Pönicke K, Block HU, Giessler C, Dunemann A, Zehl U, Förster W. Arzneimittelforschung; 1982 Jul 01; 32(3):194-200. PubMed ID: 6805480 [Abstract] [Full Text] [Related]
3. Influence of propranolol and 4-hydroxypropranolol on platelet aggregation and thromboxane A2 generation. Mehta J, Mehta P, Ostrowski N. Clin Pharmacol Ther; 1983 Nov 01; 34(5):559-64. PubMed ID: 6627818 [Abstract] [Full Text] [Related]
4. Why do some beta adrenergic agonists inhibit generation of thromboxane A2 in incubates of platelets with arachidonic acid? Chignard M, Vargaftig BB. Biochem Pharmacol; 1978 Nov 01; 27(11):1603-6. PubMed ID: 29642 [No Abstract] [Full Text] [Related]
5. Impaired platelet thromboxane production in renal failure. Smith MC, Dunn MJ. Nephron; 1981 Nov 01; 29(3-4):133-7. PubMed ID: 7329487 [Abstract] [Full Text] [Related]
6. L8027 and 1-nonyl-imidazole as non-selective inhibitors of thromboxane synthesis. Prancan AV, Lefort J, Chignard M, Gerozissis K, Dray F, Vargaftig BB. Eur J Pharmacol; 1979 Dec 20; 60(4):287-97. PubMed ID: 527664 [No Abstract] [Full Text] [Related]
10. Interference of transmethylation inhibitors with thromboxane synthesis in rat platelets: evidence for the requirement of a methyl transfer reaction in platelet activation. Lecompte T, Randon J, Chignard M, Vargaftig BB, Dray F. Adv Prostaglandin Thromboxane Leukot Res; 1983 Dec 20; 11():441-7. PubMed ID: 6221560 [No Abstract] [Full Text] [Related]
11. A dominant role of thromboxane formation in secondary aggregation of platelets. Meyers KM, Seachord CL, Holmsen H, Smith JB, Prieur DJ. Nature; 1979 Nov 15; 282(5736):331-3. PubMed ID: 503210 [No Abstract] [Full Text] [Related]
12. Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide. Allan G, Eakins KE, Kulkarni PS, Levi R. Br J Pharmacol; 1980 Nov 15; 71(1):157-64. PubMed ID: 6781572 [Abstract] [Full Text] [Related]
13. Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release. Mikhailidis DP, Jeremy JY, Barradas MA, Green N, Dandona P. Br Med J (Clin Res Ed); 1983 Nov 19; 287(6404):1495-8. PubMed ID: 6416473 [Abstract] [Full Text] [Related]
19. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. De Caterina R, Giannessi D, Gazzetti P, Bernini W. Thromb Res; 1985 Jan 15; 37(2):337-42. PubMed ID: 3975876 [No Abstract] [Full Text] [Related]
20. Platelet aggregation and thromboxane A2 formation in cat platelet rich plasma. Marcinkiewicz E, Grodzińska L, Gryglewski RJ. Pharmacol Res Commun; 1978 Jan 15; 10(1):1-12. PubMed ID: 643889 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]